Résultats de la recherche - 6 results
Premature mortality in Belgium in 1993-2009: leading causes, regional disparities and 15 years change
among men and by 22% among women over a period of 15 years. Among men, circulatory diseases death rates decreased the fastest (-43.4%), followed by the neoplasms (-26.6%), the other natural causes ...
Screening for cervical cancer in Belgium" in Description of the national situation of cervical cancer screening in the member states of the European Union
middle aged Uterine Cervical Dysplasia Uterine Cervical Neoplasms Young adult Abstract: This report up-dates information on the national situation of cervical cancer screening in the member states of the ...
What are the immunologically active components of bacille Calmette-Guérin in therapy of superficial bladder cancer?
Vaccine CD56 Antigen Humans Interferon-gamma Interleukin-12 Interleukin-2 Interleukin-6 Leukocytes, Mononuclear Neoplasm Proteins Th1 Cells Tumor Cells, Cultured Urinary Bladder Neoplasms Abstract: The ...
What is the optimal regimen for BCG intravesical therapy? Are six weekly instillations necessary?
Administration Schedule Female Follow-Up Studies Humans Immunotherapy Lymphocyte Count Male middle aged Mycobacterium bovis T-Lymphocytes Urinary Bladder Neoplasms Abstract: OBJECTIVE: For more than 20 years, BCG ...
Humoral response against heat shock proteins and other mycobacterial antigens after intravesical treatment with bacille Calmette-Guérin (BCG) in patients with superficial bladder cancer.
M Immunotherapy Lymphocytes Male middle aged Mycobacterium Mycobacterium bovis Recombinant Proteins Tetanus Toxoid Tuberculin Urinary Bladder Neoplasms Abstract: Few studies have analysed the antibody response ...
Perspectives on the integration of Immuno-Oncology Biomarkers and drugs in a Health Care setting.
Keywords: Antineoplastic Agents Biomarkers, Tumor Delivery of Health Care Humans Immunotherapy Medical Oncology Neoplasms Abstract: Immunotherapies, specifically checkpoint inhibitors, are becoming an ...